Posted on 5/25/2020
COLUMBIA, MD, May 5, 2020 – Ambu, a global manufacturer of medical devices, including single-use endoscopes, announced today that the Ambu® aView™ 2 Advance has now obtained CE mark and is listed at Food and Drug Administration which enables release for sale in Europe and North America by mid-May 2020. The aView 2 Advance is a portable full-HD display unit to be used together with our single-use endoscopes across multiple clinical specialties.
“We have pioneered single-use endoscopy for more than ten years, and we now bring our portfolio to a new level of sophistication,” said Juan Jose Gonzalez, CEO of Ambu. “Image quality is critical for healthcare providers and patient diagnosis, and we can now offer a display unit that was not possible with a single-use endoscope just a few years ago. I believe we are rais...